Dr Lal PathLabs establishes UAE subsidiary to pursue diagnostics opportunities

Shares of Dr Lal PathLabs Ltd ended at ₹1,601.20, up by ₹7.45, or 0.47%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *